课题基金 / 基金详情

Neuroprotective and disease modifying effects of GM1 and related compounds in Huntington Disease

Neuroprotective and disease modifying effects of GM1 and related compounds in Huntington Disease
GM1 和相关化合物对亨廷顿病的神经保护和疾病调节作用
批准号：
307808
负责人：
Alpaugh Melanie
金额：
$7.65万
依托单位：
University of Alberta
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-10-01 至 2016-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=307808&lang=en
关键词：
Animal Behaviour Flow Cytometry Gangliomimmetic Compounds Ganglioside Gm1 Huntington'S Disease Neurodegeneration Stereology Transgenic Mouse Models

项目摘要

项目成果

Alpaugh Melanie的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Huntington Disease (HD) is an inherited disorder that results in uncontrolled movements in early stages and loss of movement in later stages of the disease. Patients also have cognitive deficits and psychiatric disorders. These symptoms are due to the mal
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modeling blood-brain barrier dysfunctions using induced pluripotent stem cells: new insights into Huntington's disease pathology
海外基金